埃纳妥单抗
Anti-Human CD3ExBCMA (Elranatamab;PF-06863135)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human CD3ExBCMA (Elranatamab;PF-06863135)
CAS2408850-14-4
Storage condition-20°C for 3 years | In solvent: -80°C for 1 year
Security information
Product details

Elranatamab is a novel BCMA/CD3 bispecific antibody, showing promising results in RRMM. It optimally bridges BCMA on myeloma cells with CD3 on T-cells, enhancing T-cell mediated anti-myeloma activity.

Related
Sorry, no related items
History
Ercalcitriol; 1α, 25-Dihydroxyvitamin D2
Anti-Human CD49d Monoclonal Antibody(Natalizumab)
Ruplizumab (Synonyms: BG 9588; Anti-Human CD40L Recombinant Antibody)
Anti-Human RSV-F Monoclonal Antibody(Palivizumab)
Icrucumab (Anti-VEGFR1 / FLT1)
Ulocuplumab (Anti-CXCR4 / CD184)
Deruxtecan | DS-8201a | exatecan derivative | DX 8951;
Sweroside | (−)-Sweroside
Sinapaldehyde glucoside
Anti-Human CD3ExBCMA (Elranatamab;PF-06863135)